ArticleMolecules (Basel, Switzerland)2019

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.

Anroop B Nair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.